COMMENTARY
Open Access
Carpe DM: The First Global Diabetes Targets
Jeremy I. Schwartz, Kaushik Ramaiya, Margo Warren, Prashant Yadav, Grace Castillo, Roshini George and Helen McGuire
Global Health: Science and Practice April 2023, 11(2):e2200403; https://doi.org/10.9745/GHSP-D-22-00403
Jeremy I. Schwartz
aSection of General Internal Medicine, Yale University School of Medicine, New Haven, CT, USA.
bUganda Initiative for Integrated Management of Non-Communicable Diseases, Kampala, Uganda.
cCoalition for Access to NCD Medicines and Products.
Kaushik Ramaiya
cCoalition for Access to NCD Medicines and Products.
dDepartment of Internal Medicine, Shree Hindu Mandal Hospital, Dar es Salaam, Tanzania.
Margo Warren
cCoalition for Access to NCD Medicines and Products.
eAccess to Medicine Foundation, Amsterdam, The Netherlands.
Prashant Yadav
cCoalition for Access to NCD Medicines and Products.
fCenter for Global Development, Washington, DC, USA.
gTechnology and Operations Management, INSEAD, Fontainebleau, France.
Grace Castillo
cCoalition for Access to NCD Medicines and Products.
hPATH, Seattle, WA, USA.
Roshini George
cCoalition for Access to NCD Medicines and Products.
hPATH, Seattle, WA, USA.
Helen McGuire
cCoalition for Access to NCD Medicines and Products.
hPATH, Seattle, WA, USA.
Submit a Comment to This Article
Jump to comment:
No comments have been published for this article.
In this issue
Global Health: Science and Practice
Vol. 11, No. 2
April 28, 2023
Carpe DM: The First Global Diabetes Targets
Jeremy I. Schwartz, Kaushik Ramaiya, Margo Warren, Prashant Yadav, Grace Castillo, Roshini George, Helen McGuire
Global Health: Science and Practice Apr 2023, 11 (2) e2200403; DOI: 10.9745/GHSP-D-22-00403
Statistics from Altmetric.com
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.